Secretomic changes of amyloid beta peptides on Alzheimer’s disease related proteins in differentiated human SH-SY5Y neuroblastoma cells
PeerJ · 2024
DOI: 10.7717/peerj.17732 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Sittiruk Roytrakul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development A…. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Neuroblastoma, Cell Differentiation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Thailand Science Research and Innovation (TSRI) Fundamental Fund fiscal year 2022, Royal Thai Government Grant supported by Thammasat University, Thailand Science Research and Innovation.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disease that causes physical damage to neuronal connections, leading to brain atrophy. This disruption of synaptic connections results in mild to severe cognitive impairments. Unfortunately, no effective treatment is currently known to prevent or reverse the symptoms of AD. The aim of this study was to investigate the effects of three synthetic peptides, i.e., KLVFF, RGKLVFFGR and RIIGL, on an AD in vitro model represented by differentiated SH-SY5Y neuroblastoma cells exposed to retinoic acid (RA) and brain-derived neurotrophic factor (BDNF). The results demonstrated that RIIGL peptide had the least significant cytotoxic activity to normal SH-SY5Y while exerting high cytotoxicity against the differentiated cells. The mechanism of RIIGL peptide in the differentiated SH-SY5Y was investigated based on changes in secretory proteins compared to another two peptides. A total of 380 proteins were identified, and five of them were significantly detected after treatment with RIIGL peptide. These secretory proteins were found to be related to microtubule-associated protein tau (MAPT) and amyloid-beta precursor protein (APP). RIIGL peptide acts on differentiated SH-SY5Y by regulating amyloid-beta formation, neuron apoptotic process, ceramide catabolic process, and oxidative phosphorylation and thus has the potentials to treat AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand.
- Undergraduate Student of Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumtani, Thailand.
- Medical Technology Research and Service Unit, Health Care Service Center, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.
Förderung
- Thailand Science Research and Innovation (TSRI) Fundamental Fund fiscal year 2022
- Royal Thai Government Grant supported by Thammasat University
- Thailand Science Research and Innovation
- Thammasat University
Zitieren
APA
Roytrakul, S., Jaresitthikunchai, J., Phaonakrop, N., Charoenlappanit, S., Thaisakun, S., Kumsri, N., & Arpornsuwan, T. (2024). Secretomic changes of amyloid beta peptides on Alzheimer’s disease related proteins in differentiated human SH-SY5Y neuroblastoma cells. PeerJ. https://doi.org/10.7717/peerj.17732
Vancouver
Roytrakul S, Jaresitthikunchai J, Phaonakrop N, Charoenlappanit S, Thaisakun S, Kumsri N, et al. Secretomic changes of amyloid beta peptides on Alzheimer’s disease related proteins in differentiated human SH-SY5Y neuroblastoma cells. PeerJ. 2024. doi:10.7717/peerj.17732
BibTeX
@article{Roytrakul2024,
author = {Roytrakul, Sittiruk and Jaresitthikunchai, Janthima and Phaonakrop, Narumon and Charoenlappanit, Sawanya and Thaisakun, Siriwan and Kumsri, Nitithorn and Arpornsuwan, Teerakul},
title = {Secretomic changes of amyloid beta peptides on Alzheimer’s disease related proteins in differentiated human SH-SY5Y neuroblastoma cells},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.17732}
}
EUVIMED